Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Bio-gener Technology has established itself as a leading supplier of molecular diagnostic laboratory equipment in China. Their product lines include real-time PCR analyzers, fully automated nucleic acid extractors, gene amplifiers/thermal cyclers, reagents for nucleic acid testing, consumables such as sample preservation solutions and containers. The company’s ecosystem covers "instruments + reagents + consumables + raw materials" across the value chain of the PCR industry. No clinical trial results apply since they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Bio-Gener Technology.